Analyst Reco. Cerence Inc.

Equities

CRNC

US1567271093

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-31 pm EDT			5-day change	1st Jan Change
3.44 ^USD	-3.91%		+7.17%	-82.50%

May. 17	Cerence Chief Financial Officer Resigns for Personal Reasons	MT
May. 16	Cerence Inc. Announces Chief Financial Officer Changes	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Baird Adjusts Cerence Price Target to $8 From $15, Maintains Neutral Rating	May. 10	MT
Wedbush Adjusts Cerence's Price Target to $9 From $21, Keeps Neutral Rating	May. 10	MT
Wells Fargo Downgrades Cerence to Equalweight From Overweight, Price Target at $6.50	May. 10	MT
Baird Adjusts Price Target on Cerence to $15 From $17, Maintains Neutral Rating	Apr. 17	MT
Wedbush Raises Cerence's Price Target to $21 From $19 After Higher-Than-Expected Fiscal Q1 Results, Keeps Neutral Rating	Feb. 07	MT
Craig-Hallum Downgrades Cerence to Hold From Buy, Price Target is $22	Feb. 07	MT
North American Morning Briefing : Rate Doubts Keep -2-	Feb. 06	DJ
Goldman Sachs Cuts Price Target on Cerence to $19 From $28 Amid Lower Outlook; Maintains Neutral Rating	Nov. 29	MT
Goldman Sachs Cuts Price Target on Cerence to $19 From $28 Amid Cut to Multi-Year Outlook, Lower Peer Multiples; Neutral Rating Kept	Nov. 29	MT
Wells Fargo Cuts Cerence's Price Target to $25 From $32, Maintains Overweight Rating	Nov. 28	MT
Needham Adjusts Cerence's Price Target to $23 From $34, Keeps Buy Rating	Nov. 28	MT
Wedbush Cuts Cerence's PT to $19 From $31 on Lower Multiple, Says Large Legacy Contract Write-Down to Overshadow Fiscal Year 2024 Guidance; Keeps Neutral Rating	Nov. 28	MT
Wedbush Raises Cerence's Price Target to $31 From $26 After Higher-Than-Expected Fiscal Q3 Results, Keeps Neutral Rating	23-08-09	MT
Wedbush Cuts Cerence's Price Target to $26 From $32, Keeps Neutral Rating	23-05-11	MT
Goldman Sachs Adjusts Price Target on Cerence to $28 From $31, Maintains Neutral Rating	23-05-10	MT
Wedbush Raises Cerence's Price Target to $32 From $25 After Above-Street Fiscal Q1 Results, Keeps Neutral Rating	23-02-10	MT
Goldman Sachs Adjusts Price Target on Cerence to $31 From $19, Maintains Neutral Rating	23-02-09	MT
Baird Adjusts Price Target on Cerence to $30 From $23, Maintains Neutral Rating	23-02-09	MT
Wells Fargo Adjusts Price Target on Cerence to $32 From $25, Maintains Overweight Rating	23-02-09	MT
Needham Adjusts Cerence's Price Target to $42 From $40, Keeps Buy Rating	23-02-09	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Cerence Inc.

Equities

CRNC

US1567271093

Analyst Reco.

Filters